Why is Rossari Biotech falling/rising?

As of 24-Sep, Rossari Biotech Ltd is experiencing a decline in its stock price, currently at 654.35, which reflects a decrease of 3.05 or 0.46%. The stock has been on a downward trend, losing value for the last three consecutive days and recording a total decline of 2.68% during this period. Despite a recent 1-week gain of 2.72%, the stock has significantly underperformed over the longer term, with a year-to-date drop of 16.93% and a staggering 30.68% decline over the past year. The stock's performance today is in line with its sector, but it is noteworthy that the delivery volume has fallen sharply by 82.79% compared to the 5-day average, indicating reduced investor participation. Additionally, while the company maintains a low debt-to-equity ratio and attractive valuation metrics, its profits have decreased by 1% over the past year, contributing to the negative sentiment.
In the broader market context, Rossari Biotech's short-term performance contrasts with the benchmark, as the Sensex has shown a decline of 1.18% over the same week. The stock's consistent underperformance against the benchmark over the last three years, coupled with flat results reported in June 2025 and the lowest return on capital employed (ROCE) at 14.46%, raises concerns among investors. Although institutional holdings are relatively high at 21.32%, suggesting some level of confidence from larger investors, the overall trend indicates a lack of momentum and investor interest, further exacerbating the stock's decline.